Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-methylfolate for Treatment-Resistant GAD
NCT06218030Phase 4Recruiting
- Sponsor
- Queen's University
- Start
- Oct 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of 5-MTHF in generalized anxiety disorder (GAD), sponsored by Queen's University. Started Oct 2024; status: recruiting.
02
Drugs
5-MTHF
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT06218030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218030.